By Ben Glickman
Shares of GlycoMimetics rose Tuesday after its chief medical officer bought over $90,000 worth of stock.
The stock was up 12% to $1.44 in afternoon trading. Shares have fallen 53% this year.
The Rockville, Md.-based biotechnology company disclosed Monday after the market close that medical chief Edwin Rock had purchased 65,403 shares from Sept. 21 to Sept. 22 at a purchase price of $1.38 a share.
Rock’s purchase, valued at $90,256, brings his direct holdings to 375,403 shares.
Write to Ben Glickman at [email protected]
Read the full article here
